1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase

被引:173
作者
Perry, PJ
Gowan, SM
Reszka, AP
Polucci, P
Jenkins, TC
Kelland, LR
Neidle, S
机构
[1] Inst Canc Res, Canc Res Campaign, Biomol Struct Unit, Sutton SM2 5NG, Surrey, England
[2] Inst Canc Res, Ctr Canc Therapeut, Canc Res Campaign, Sutton SM2 5NG, Surrey, England
[3] Univ Camerino, Dept Chem, I-62032 Camerino, Italy
关键词
D O I
10.1021/jm9801105
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A number of 1,4- and 2,6-difunctionalized amidoanthracene-9, l0-diones have been prepared. We have examined their in vitro cytotoxicity in several tumor cell lines and their ability to inhibit the telomere-addition function of the human telomerase enzyme together with their inhibition of the Taq polymerase enzyme. Compounds with -(CH2)(2)- side chains terminating in basic groups such as piperidine show inhibition of telomerase at (IC50)-I-tel levels of 4-11 mu M. These are thus among the most potent nonnucleoside telomerase inhibitors reported to date. Cytotoxicity levels in human tumor cell lines were at comparable levels for several compounds. Implications for amidoanthracene-9,10-dione telomerase inhibitors as potential anticancer agents are discussed.
引用
收藏
页码:3253 / 3260
页数:8
相关论文
共 41 条
  • [1] ANTHRACENE-9,10-DIONES AS POTENTIAL ANTICANCER AGENTS - SYNTHESIS, DNA-BINDING, AND BIOLOGICAL STUDIES ON A SERIES OF 2,6-DISUBSTITUTED DERIVATIVES
    AGBANDJE, M
    JENKINS, TC
    MCKENNA, R
    RESZKA, AP
    NEIDLE, S
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (08) : 1418 - 1429
  • [2] EVIDENCE FOR A CRITICAL TELOMERE LENGTH IN SENESCENT HUMAN FIBROBLASTS
    ALLSOPP, RC
    HARLEY, CB
    [J]. EXPERIMENTAL CELL RESEARCH, 1995, 219 (01) : 130 - 136
  • [3] Porphyrin binding to quadruplexed T4G4
    Anantha, NV
    Azam, M
    Sheardy, RD
    [J]. BIOCHEMISTRY, 1998, 37 (09) : 2709 - 2714
  • [4] STRUCTURE AND FUNCTION OF TELOMERES
    BLACKBURN, EH
    [J]. NATURE, 1991, 350 (6319) : 569 - 573
  • [5] Telomere shortening and tumor formation by mouse cells lacking telomerase RNA
    Blasco, MA
    Lee, HW
    Hande, MP
    Samper, E
    Lansdorp, PM
    DePinho, RA
    Greider, CW
    [J]. CELL, 1997, 91 (01) : 25 - 34
  • [6] Extension of life-span by introduction of telomerase into normal human cells
    Bodnar, AG
    Ouellette, M
    Frolkis, M
    Holt, SE
    Chiu, CP
    Morin, GB
    Harley, CB
    Shay, JW
    Lichtsteiner, S
    Wright, WE
    [J]. SCIENCE, 1998, 279 (5349) : 349 - 352
  • [7] Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines
    Bryan, TM
    Englezou, A
    DallaPozza, L
    Dunham, MA
    Reddel, RR
    [J]. NATURE MEDICINE, 1997, 3 (11) : 1271 - 1274
  • [8] Telomerase activity and survival of patients with node-positive breast cancer
    Clark, GM
    Osborne, CK
    Levitt, D
    Wu, F
    Kim, NW
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (24) : 1874 - 1881
  • [9] SYNTHESIS, MOLECULAR MODELING, DNA-BINDING, AND ANTITUMOR PROPERTIES OF SOME SUBSTITUTED AMIDOANTHRAQUINONES
    COLLIER, DA
    NEIDLE, S
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (04) : 847 - 857
  • [10] TELOMERASE ACTIVITY IN HUMAN OVARIAN-CARCINOMA
    COUNTER, CM
    HIRTE, HW
    BACCHETTI, S
    HARLEY, CB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (08) : 2900 - 2904